This is exemplified by heterozygous gain of function mutations in RET which are associated with thyroid carcinoma and multiple endocrine neoplasia types 2A and 2B versus homozygous loss of function mutations in Hirschsprung disease [26]. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.